Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

Changes in Skin Color: Clinical Perspectives

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinicopathologic correlation of dermatologic diseases in patients with darker pigmentation.

American journal of clinical pathology·2024

Same author

Cutaneous Sarcoidosis in Skin of Color.

Journal of drugs in dermatology : JDD·2023

Same author

Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center.

Dermatologic therapy·2021

Same author

Effect of in-office samples on dermatologists' prescribing habits: a retrospective review.

Cutis·2020

Same author

Survey analysis on the management of moderately dysplastic nevi among academic dermatologists across the United States.

Journal of the American Academy of Dermatology·2018

Same author

Recalcitrant Diffuse Cutaneous Sarcoidosis With Perianal Involvement Responding to Adalimumab.

Journal of drugs in dermatology : JDD·2017

Search research articles

Related Experiment Video

Updated: May 25, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Advanced treatment modalities for vitiligo.

Nishit S Patel¹, Kapila V Paghdal, George F Cohen

¹Department of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, Florida, USA. npatel85@gmail.com

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]

|February 1, 2012

Summary

This summary is machine-generated.

Vitiligo treatment can be challenging, as many patients do not respond to traditional therapies. Advanced techniques like excimer lasers and surgical grafting offer effective options for difficult-to-treat vitiligo cases.

More Related Videos

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

Related Experiment Videos

Last Updated: May 25, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

Area of Science:

Dermatology
Immunology

Background:

Vitiligo is a polygenic dyschromia affecting 1-3% of the global population.
Characterized by depigmented macules and patches.
Traditional pharmacologic treatments have limited success in nearly half of patients.

Purpose of the Study:

To review advanced treatment modalities for vitiligo.
To provide a practical guide for their application.
To address treatment-resistant cases.

Main Methods:

Literature review of advanced vitiligo treatments.
Analysis of techniques including 308-nm excimer laser, depigmentation therapy, microdermabrasion, micropigmentation, khellin-UVA, and surgical grafting (miniature punch, suction blister, epidermal cultures).

Main Results:

Advanced techniques offer alternatives for non-responders to traditional therapy.
Specific modalities detailed for dermatological application.
Successful outcomes achievable even in refractory cases.

Conclusions:

Vitiligo treatment can be challenging but achievable.
Appropriate patient selection is crucial.
Careful application of advanced therapies leads to successful outcomes in refractory vitiligo.